STC-1010
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for STC-1010, covering 2025-12-22 to 2025-12-22. Get the full timeline:
Most recent: Clinical Trial Update: First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer [Phase 1, Phase 2]